Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Progesterone-modified Natural Cycle for FET

Hormone replacement therapy (HRT) cycles, despite the ease of synchronizing embryo thawing and embryo transfer timing, increase the risk of pregnancies and obstetric complications compared to natural cycles (NC). By ensuring the presence of the corpus luteum while reducing the number of monitoring sessions, the progesterone modified natural cycle (P4mNC) offers more convenience for the patient than the normal NC. This study is designed to compare the effects of P4mNC and HRT cycles on FET outcomes.

Participants needed: 336
Trial details
Phase: Phase 3Age: 21-44Biological sex: FemaleType: InterventionalSponsor: Shandong University of Traditional Chinese MedicineUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Patients aged 21 to 44 years undergoing FBT [+2]

Untreated uterine adhesions [+3]

Status: Recruiting

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

The purpose of this study is to investigate whether oral Gushen Antai pills supplementation for luteal phase support will improve ongoing pregnancy rate in women with normal ovarian reserve in fresh embryo transfer cycles.

Participants needed: 800
Trial details
Phase: Phase 4Age: 21-42Biological sex: FemaleType: InterventionalSponsor: Shandong University of Traditional Chinese MedicineUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Patients with normal ovarian function reserve (5 ≤ AFC ≤ 15, 1.2 ng/ml ≤ AMH ≤ 3... [+3]

Age ≥ 43 years old. [+12]